$NWBO Recent Headlines 7 Biotechnology Stocks to Buy

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$NWBO Recent Headlines

7 Biotechnology Stocks to Buy Now 5:30 a.m. Sept. 3, 2014 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Aug. 27, 2014 - InvestorPlace.com
Northwest Bio closes convertible debt offering 4:41 p.m. Aug. 25, 2014 - Seeking Alpha
8 Biotechnology Stocks to Buy Now 6:15 a.m. Aug. 20, 2014 - InvestorPlace.com
8 Biotechnology Stocks to Buy Now 6:15 a.m. Aug. 20, 2014 - InvestorPlace.com
Northwest Bio Can't Keep its DC-Vax Claims Straight 10:20 a.m. Aug. 14, 2014 - TheStreet.com
10 Cheap Stocks to Buy Now Under $10 10:20 a.m. Aug. 14, 2014 - InvestorPlace.com
Northwest Bio: The Data Monitoring Committee Addresses The Status Of The DCVax-L Trial 6:17 p.m. Aug. 13, 2014 - Seeking Alpha
Northwest Bio - You Can See This Data, But Not That Data 9:35 a.m. Aug. 13, 2014 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:15 a.m. Aug. 13, 2014 - InvestorPlace.com
Northwest Bio DC-Vax Study Changes Hint at Failure 11:18 a.m. Aug. 12, 2014 - TheStreet.com
Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies 10:43 a.m. Aug. 12, 2014 - Seeking Alpha
8 Biotechnology Stocks to Buy Now 5:00 a.m. Aug. 6, 2014 - InvestorPlace.com
11 Biotechnology Stocks to Buy Now 5:45 a.m. July 30, 2014 - InvestorPlace.com
7 Biotechnology Stocks to Buy Now 6:00 a.m. July 23, 2014 - InvestorPlace.com
Northwest Bio And The Curious Relationship With Cognate BioServices 6:55 p.m. July 17, 2014 - Seeking Alpha
Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Scheme To Promote NWBO 8:25 a.m. July 17, 2014 - Seeking Alpha
Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme 8:25 a.m. July 17, 2014 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 6:30 a.m. July 16, 2014 - InvestorPlace.com
Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer 2:40 p.m. July 15, 2014 - Seeking Alpha


NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2:44 p.m. Aug. 19, 2014 - PR Newswire - PRF
NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES 11:47 a.m. Aug. 14, 2014 - PR Newswire - PRF
NW BIO CORRECTS ONGOING FALSE CLAIMS BY FEUERSTEIN ABOUT PHASE III TRIAL OF DCVAX®-L, AND INTERIM ANALYSIS 9:26 a.m. Aug. 13, 2014 - PR Newswire - PRF
NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
NW BIO PROVIDES UPDATE ABOUT PHASE III DCVAX®-L TRIAL FOR GBM AND "INFORMATION ARM" COMPASSIONATE USE PATIENTS 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
Small companies lead the I-O class of Cancer Therapies 8:02 a.m. Aug. 8, 2014 - ACCESSWIRE
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 4:45 p.m. July 30, 2014 - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Northwest Biotherapeutics, Inc. Stockholders 7:13 p.m. July 23, 2014 - BusinessWire - BZX
NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 4:55 p.m. July 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 6:23 p.m. July 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northwest Biotherapeutics, Inc. - NWBO 6:31 p.m. July 7, 2014 - PR Newswire - PRF
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Northwest Biotherapeutics, Inc. (NWBO) To Contact The Firm 1:17 p.m. July 4, 2014 - PR Newswire - PRF
Biotech Stocks on the Move -- Research on CTI BioPharma, BioMarin Pharma, Vertex Pharma, and Northwest Biotherapeutics 7:00 a.m. June 27, 2014 - PR Newswire - PRF
Completed Acquisitions, Index Inclusions, and Conditional Drug Approvals - Analyst Notes on Universal Health Services, Brookdale, Envision Healthcare, Karyopharm and NW Bio 5:30 a.m. June 26, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 4:50 p.m. June 25, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northwest Biotherapeutics, Inc. -- NWBO 5:37 p.m. June 23, 2014 - GlobeNewswire
NW BIO REAFFIRMS DCVAX®-DIRECT CLINICAL TRIAL INTERIM DATA ANNOUNCEMENTS 8:25 a.m. June 20, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Investigation on Behalf of Northwest Biotherapeutics, Inc. Investors Announced by Law Offices of Howard G. Smith 4:32 p.m. June 19, 2014 - BusinessWire - BZX
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Northwest Biotherapeutics, Inc. 2:30 p.m. June 19, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Florida Cancer Institute Expands: New Oncologist Joins Team

Updated Category News Views 0

News in the medical world isn't just rattling desks today; it's a purposeful signal for cancer care's transformation. Florida Cancer Specialists & Research Institute (FCS) has beefed up its team, embracing Carlos Barbur, DO, an oncologist who's not just skilled but steeped in disciplines crucial for the health of many. Think of this as another puzzle piece fitting snugly...

Continue Reading
ENGWE Unleashes Massive Black Friday E-Bike Discounts

Updated Category News Views 70

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Continue Reading
ElektraFi Challenges Starlink: Fixed Wireless Gains Edge

Updated Category News Views 36

Revolution or Just Better Options? In the wild west of internet connectivity, where every home is a frontier, ElektraFi is throwing down the gauntlet at the feet of behemoths like Starlink. They're talking big about their fixed wireless network, and in places stretching from Colorado's ski slopes to the dustier reaches of Texas, that talk might just hold some weight. Why...

Continue Reading
Celebree's Gratitude Push: Kindness Turns into Action

Updated Category News Views 80

Expressing Gratitude: More than Just Words Gratitude: it's one of those feel-good concepts that everyone nods to, but let's face it—most folks don't really go beyond the occasional 'thanks.' That's where the Generation Gratitude Project by Celebree School steps in. The idea's not just about saying thanks, but about making it a real, action-oriented habit. This campaign,...

Continue Reading
Fresenius, WuXi Biologics Blaze New Biosimilars Trail

Updated Category News Views 115

Fresenius Bets Big on Biopharma with WuXi Partnership A deal inked by Fresenius and WuXi Biologics is stirring up the biosimilars pot, aiming to widen Fresenius' grip on the market tenfold. We're not talking small potatoes here; we're talking up to 66 biosimilar molecules against a hefty backdrop of more than €370 billion in originator sales. It's as if they've said,...

Continue Reading
Leadership Shifts in AAOMS: Dr. Crago at Helm

Updated Category News Views 11

New Guard at AAOMS: Dr. Crago Takes Charge With a blend of experience and a fresh theme, Dr. Charles A. Crago steps into the presidential shoes of the American Association of Oral and Maxillofacial Surgeons (AAOMS) for the 2026-27 term. Frankly, navigating leadership isn't new to Crago. I mean, after serving a lifetime in varied roles—President-Elect, Vice President,...

Continue Reading
Enterprise Networking Set for Big Growth by 2032

Updated Category News Views 63

Enterprise Networking's Growth Trajectory When the digits start rolling in at a compound annual growth rate of a neat 10.1%, you know there's a story worth watching. This tale of enterprise networking gaining traction is a head-turner, anticipated to soar from $134.59 billion in 2026 to a hefty $239.92 billion by 2032. Hold onto your hats—there's a storm of change...

Continue Reading
Composites One Unveils Game-Changing eCommerce Platform

Updated Category News Views 7

A New Era for Composites One? You know how companies often blast updates nobody asked for? Well, Composites One finally flipped the script. They've rolled out a completely revamped eCommerce platform across North America, and here's the kicker—it's actually built from the ground up on customer feedback. Yeah, they took the time to ask manufacturers what they needed for...

Continue Reading
New Leadership Fuels Expansion of Black Optix Tint

Updated Category News Views 23

Shifting Gears with New Leadership Black Optix Tint isn't just revamping its car-styling game; it's refueling the entire brand with the appointment of Jeff Stark as its new brand president. This guy's entry into the picture is like putting nitro in the tank of a franchise that's already got some serious road miles behind it. With over 15 years under his belt in the...

Continue Reading
UFC Gym Expands, Opening Murfreesboro Location Soon

Updated Category News Views 0

UFC GYM Targets the Heart of Murfreesboro They're doing it again—UFC GYM's tossing another gym into the mix, folks! This time, it's Murfreesboro, Tennessee, catching the brand's punchy, high-energy splash. Don't mistake this for just another big-box, bench-press-jamboree. Their doors swing open come November 14, and this ain't some punk move. We're talking a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Byrna Technologies Earnings Preview: What Investors Need to Know

Updated Category News Views 143

Byrna Technologies Earnings Preview Byrna Technologies (NASDAQ: BYRN) is preparing to deliver its quarterly earnings report, and anticipation is building among investors regarding its performance. To fully understand what to expect, let’s delve into several key points surrounding this earnings announcement. Analyst Earnings Expectations Analysts are predicting that...

Continue Reading
LifeVantage Celebrates Acquisition of LoveBiome for Growth

Updated Category News Views 319

LifeVantage Announces Acquisition of LoveBiome LifeVantage Corporation, a recognized health and wellness entity, recently completed the acquisition of LoveBiome, an innovative direct sales company specialized in comprehensive microbiome care. This significant move marks a pivotal step for LifeVantage, known for its commitment to enhancing cellular health with products...

Continue Reading
Nabsys Earns ISO 9001:2015 Certification, Elevating Quality Standards

Updated Category News Views 149

Nabsys Achieves ISO 9001:2015 Certification Nabsys 2.0, LLC, known for its advancements in electronic genome mapping technology, has successfully earned ISO 9001:2015 certification. This prestigious certification exemplifies Nabsys' dedication to quality management and their commitment to delivering top-notch products and services. Quality Management and Customer Focus...

Continue Reading
High-Performance Computing Market Growth to USD 92.33 Billion

Updated Category News Views 142

High-Performance Computing Market Size Analysis The High-Performance Computing (HPC) market is poised for remarkable growth, with projections indicating an increase from USD 47.07 billion in 2023 to USD 92.33 billion by 2032. This expansion is fueled by a compound annual growth rate (CAGR) of 7.80% from 2024 to 2032. Market Analysis and Demand Drivers High-performance...

Continue Reading
Metagenomi's Groundbreaking Presentations at Scientific Events

Updated Category News Views 140

Metagenomi's Upcoming Presentations at Leading Scientific Conferences Metagenomi, Inc. (Nasdaq: MGX), a pioneering force in precision genetic medicine, is set to share its innovative approaches and advancements in the field through multiple presentations at highly regarded scientific conferences. The company is dedicated to developing curative therapeutics utilizing its...

Continue Reading